MGO One Seven’s Cardiol Therapeutics CRDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$166K Hold
100,000
– – ﹤0.01% 1487
2026
Q2
$106K Hold
100,000
– – ﹤0.01% 1513
2026
Q1
$135K Hold
100,000
– – ﹤0.01% 1367
2025
Q4
$95.4K Hold
100,000
– – ﹤0.01% 1369
2025
Q3
$107K Hold
100,000
– – ﹤0.01% 1293
2025
Q2
$136K Hold
100,000
– – ﹤0.01% 1162
2025
Q1
$97K Hold
100,000
– – ﹤0.01% 1065
2024
Q4
$128K Hold
100,000
– – ﹤0.01% 1035
2024
Q3
$198K Hold
100,000
– – 0.01% 941
2024
Q2
$202K Hold
100,000
– – 0.01% 909
2024
Q1
$181K Hold
100,000
– – 0.01% 853
2023
Q4
$84.3K Hold
100,000
– – ﹤0.01% 877
2023
Q3
$89.5K Hold
100,000
– – 0.01% 804
2023
Q2
$89K Buy
+100,000
New +$66K 0.01% 764
2022
Q4
– Sell
-10,000
Closed -$10K – 748
2022
Q3
$10K Hold
10,000
– – ﹤0.01% 712
2022
Q2
$13K Buy
+10,000
New +$14.2K ﹤0.01% 639

Other funds holding CRDL

MGO One Seven's CRDL Position: Q3 2026 in Review

MGO One Seven held its Cardiol Therapeutics (CRDL) position steady in Q3 2026 at 100,000 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

MGO One Seven first reported a position in CRDL in Q2 2022 and has held it in 16 quarters since. The position peaked at $202K in Q2 2024. 59 funds tracked by Wall St. Rank hold CRDL as of Q3 2026.

  • MGO One Seven held 100,000 shares of Cardiol Therapeutics worth $166K as of Q3 2026.
  • MGO One Seven left its Cardiol Therapeutics share count unchanged in Q3 2026.
  • Cardiol Therapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q3 2026, its #1487 holding.
  • MGO One Seven first reported a position in Cardiol Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • MGO One Seven's Cardiol Therapeutics position peaked at $202K in Q2 2024.
  • 59 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q3 2026.

Based on MGO One Seven's 13F filing for Q3 2026, filed 28 Oct 2026.